Article Details

Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy ...

Retrieved on: 2022-11-04 07:58:01

Tags for this article:

Click the tags to see associated articles and topics

Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy .... View article details on HISWAI: https://pipelinereview.com/index.php/2022110481960/Antibodies/Affimed-and-Artiva-Biotherapeutics-Announce-Partnership-to-Advance-Combination-Therapy-of-Innate-Cell-Engager-ICE-AFM13-and-Off-the-Shelf-Allogeneic-NK-Cell-Therapy-AB-101.html

Excerpt

"We are developing AB-101 as a universal ADCC enhancer when combined with monoclonal antibodies and NK cell engagers,” said Dr. Fred Aslan, ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up